Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Open Access
- 19 October 2011
- journal article
- research article
- Published by Springer Nature in BMC Immunology
- Vol. 12 (1) , 59
Abstract
Background: The balancing functions of pro/anti-inflammatory mediators of the complex innate responses have been investigated in a variety of experimental inflammatory settings. Annexin-A1 (AnxA1) is one mediator of endogenous anti-inflammation, affording regulation of leukocyte trafficking and activation in many contexts, yet its role in lung pathologies has been scarcely investigated, despite being highly expressed in lung cells. Here we have applied the bleomycin lung fibrosis model to AnxA1 null mice over a 21-day time-course, to monitor potential impact of this mediator on the control of the inflammatory and fibrotic phases. Results: Analyses in wild-type mice revealed strict spatial and temporal regulation of the Anxa1 gene, e.g. up-regulation in epithelial cells and infiltrated granulocytes at day 7, followed by augmented protein levels in alveolar macrophages by day 21. Absence of AnxA1 caused increases in: i) the degree of inflammation at day 7; and ii) indexes of fibrosis (assessed by deposition of hydroxyproline in the lung) at day 7 and 21. These alterations in AnxA1 null mice were paralleled by augmented TGF-β1, IFN-γ and TNF-α generation compared to wild-type mice. Finally, treatment of wild type animals with an AnxA1 peptido-mimetic, given prophylactically (from day 0 to 21) or therapeutically (from day 14 onward), ameliorated both signs of inflammation and fibrosis. Conclusion: Collectively these data reveal a pathophysiological relevance for endogenous AnxA1 in lung inflammation and, more importantly, fibrosis, and may open new insights for the pharmacological treatment of lung fibrosis.Keywords
This publication has 52 references indexed in Scilit:
- Mesenchymal Stem Cells Modulate Lung InjuryProceedings of the American Thoracic Society, 2010
- Nonresolving InflammationCell, 2010
- Annexin‐A1: a pivotal regulator of the innate and adaptive immune systemsBritish Journal of Pharmacology, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- Annexin 1 Cleavage in Activated NeutrophilsJournal of Biological Chemistry, 2007
- Complex Regulation of Pulmonary Inflammation and Fibrosis by CCL18The American Journal of Pathology, 2007
- Post‐translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surfaceThe FASEB Journal, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanismBritish Journal of Pharmacology, 2000
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970